NuTec, IBM To Implement Tumor Gene Targeting System at Emory Hospital | GenomeWeb

NEW YORK, May 3 – Moving forward on a promise to invest $100 million in genomics-directed technology, IBM’s life sciences unit announced Thursday a collaboration with NuTec Sciences and Emory University’s Winship Cancer Institute to screen individual patients for specific tumor-associated genes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.